Mathias Tyo-Gomez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mathias Tyo-Gomez has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Bruno Michon
Centre Mère-Enfant Soleil, CHU de Québec-Université Laval, Québec, QC G1V 4G2, Canada
1 shared publication - Julie Felipe
Department of Psychology, Université de Montréal, Montreal, QC H3C 3J7, Canada
1 shared publication - Lye-Ann Robichaud
Université de Montréal Montréal Canada
1 shared publication - Marc-Antoine Marquis
CHU Sainte-Justine Research Center , Sainte-Justine University Hospital, Montréal, QC
1 shared publication - Marianne Olivier-D’avignon
School of Social Work, Université Laval, Québec, QC G1V 0A6, Canada
1 shared publication - Michel Duval
Centre de Recherche, Centre Hospitalier Universitaire Sainte-Justine, Montréal, Canada
1 shared publication
Latest Publications
- Open Access
- 19 April 2024
- Published by MDPI AG in Current Oncology
- Vol. 31 (4) , 2289-2304
Quality-of-Life Assessment in Pediatric Advanced Cancer: Development of the Patient-Reported Outcome Measure Advance QoL
A recent measure was developed to assess the Quality of Life (QoL) of young people with advanced cancer and is available for parents and professionals (Advance QoL). The present study aimed to elaborate self-reported versions for children and adolescents with advanced cancer. We adopted a four-phase research plan: (1) to elaborate the Advance QoL questionnaire for youth (8–12 and 13–18 years old) with a team of young research partners; (2) to evaluate the understandability of these versions in a sample of 12 young patients from the target population using cognitive interviews; (3) to assess social validity in the same group using a questionnaire and the content validity index (CVI); and (4) to refine the questionnaires according to these results. Four major themes were identified: (1) issues affecting the understanding of the tool; (2) issues that did not affect the understanding of the tool; (3) modifications to improve the tool; and (4) positive features of the tool. Advance QoL was well received, and feedback was positive. Adjustments were made according to young people’s comments and two self-reported versions are now available. It is essential to measure the key domains of QoL in advanced cancer. Advance QoL self-report versions will help target the specific needs of young people with this condition and their families.
- 19 April 2024
- Published by MDPI AG in Current Oncology
- Vol. 31 (4) , 2289-2304
Open AccessQuality-of-Life Assessment in Pediatric Advanced Cancer: Development of the Patient-Reported Outcome Measure Advance QoL
A recent measure was developed to assess the Quality of Life (QoL) of young people with advanced cancer and is available for parents and professionals (Advance QoL). The present study aimed to elaborate self-reported versions for children and adolescents with advanced cancer. We adopted a four-phase research plan: (1) to elaborate the Advance QoL questionnaire for youth (8–12 and 13–18 years old) with a team of young research partners; (2) to evaluate the understandability of these versions in a sample of 12 young patients from the target population using cognitive interviews; (3) to assess social validity in the same group using a questionnaire and the content validity index (CVI); and (4) to refine the questionnaires according to these results. Four major themes were identified: (1) issues affecting the understanding of the tool; (2) issues that did not affect the understanding of the tool; (3) modifications to improve the tool; and (4) positive features of the tool. Advance QoL was well received, and feedback was positive. Adjustments were made according to young people’s comments and two self-reported versions are now available. It is essential to measure the key domains of QoL in advanced cancer. Advance QoL self-report versions will help target the specific needs of young people with this condition and their families.